Literature DB >> 21059795

Quantitative assessment of mammary gland development in female Long Evans rats following in utero exposure to atrazine.

Russell C Hovey1, Pragati Sawhney Coder, Jeffrey C Wolf, Robert L Sielken, Merrill O Tisdel, Charles B Breckenridge.   

Abstract

In this study, we quantified the effects of in utero exposure to the herbicide atrazine on subsequent mammary gland development. Atrazine was administered to pregnant female Long Evans rats from gestation days 13-19 at doses of 0, 6.5, 50, or 100 mg/kg/day. A pair-fed control group was yoked to the high-dose atrazine-treated group. Litter size was standardized to 10 pups on postnatal day (PND) 4. Whole mounts of the left fourth mammary gland and histologic sections of the right fourth gland were obtained from a subgroup of offspring on PND1, 21, 33, on day of vaginal opening (VO), or around PND65 at diestrus. A blinded, quantitative analysis of key morphological features in mammary gland whole mounts (ductal elongation, ductal network area, epithelial area, terminal end bud [TEB] incidence, and epithelial density) as well as epithelial proliferation within different parenchymal structures was conducted. There was no effect of atrazine exposure on any of the measures of mammary gland development at the maternal dose of 6.5 mg/kg/day. On PND1, ductal elongation was increased by approximately 20% (p < 0.05) in the female offspring born to dams exposed to 50 and 100 mg/kg/day atrazine, coincident with decreased epithelial proliferation in the 100 mg/kg/day group at this age. These differences were not present on PND21, or thereafter. An increased incidence of TEB in the mammary glands from females that were born to both the pair-fed and 50 mg/kg/day-treated dams at the time of VO indicated that this response was a specific result of maternal caloric restriction. Collectively, these data indicate that maternal atrazine exposure has no long-term effects on mammary gland development in female offspring beyond a transitory response to high doses at PND1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059795     DOI: 10.1093/toxsci/kfq337

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  13 in total

Review 1.  State of the evidence 2017: an update on the connection between breast cancer and the environment.

Authors:  Janet M Gray; Sharima Rasanayagam; Connie Engel; Jeanne Rizzo
Journal:  Environ Health       Date:  2017-09-02       Impact factor: 5.984

2.  Scientific and Regulatory Policy Committee (SRPC) Points to Consider: Histopathology Evaluation of the Pubertal Development and Thyroid Function Assay (OPPTS 890.1450, OPPTS 890.1500) in Rats to Screen for Endocrine Disruptors.

Authors:  Kevin A Keane; George A Parker; Karen S Regan; Catherine Picut; Darlene Dixon; Dianne Creasy; Dipak Giri; Renee R Hukkanen
Journal:  Toxicol Pathol       Date:  2015-05-06       Impact factor: 1.902

3.  Quantifying Branching Density in Rat Mammary Gland Whole-mounts Using the Sholl Analysis Method.

Authors:  Jason P Stanko; Suzanne E Fenton
Journal:  J Vis Exp       Date:  2017-07-12       Impact factor: 1.355

4.  Application of Sholl analysis to quantify changes in growth and development in rat mammary gland whole mounts.

Authors:  Jason P Stanko; Michael R Easterling; Suzanne E Fenton
Journal:  Reprod Toxicol       Date:  2014-11-15       Impact factor: 3.143

5.  Commentary: cumulative risk assessment of perfluoroalkyl carboxylic acids and perfluoralkyl sulfonic acids: what is the scientific support for deriving tolerable exposures by assembling 27 PFAS into 1 common assessment group?

Authors:  Thomas Colnot; Wolfgang Dekant
Journal:  Arch Toxicol       Date:  2022-08-17       Impact factor: 6.168

6.  Differences in the Rate of in Situ Mammary Gland Development and Other Developmental Endpoints in Three Strains of Female Rat Commonly Used in Mammary Carcinogenesis Studies: Implications for Timing of Carcinogen Exposure.

Authors:  Jason P Stanko; Grace E Kissling; Vesna A Chappell; Suzanne E Fenton
Journal:  Toxicol Pathol       Date:  2016-09-09       Impact factor: 1.902

Review 7.  Impaired mitochondrial metabolism and mammary carcinogenesis.

Authors:  Nagendra Yadava; Sallie S Schneider; D Joseph Jerry; Chul Kim
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-12-27       Impact factor: 2.673

Review 8.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

9.  Atrazine and breast cancer: a framework assessment of the toxicological and epidemiological evidence.

Authors:  James W Simpkins; James A Swenberg; Noel Weiss; David Brusick; J Charles Eldridge; James T Stevens; Robert J Handa; Russell C Hovey; Tony M Plant; Timothy P Pastoor; Charles B Breckenridge
Journal:  Toxicol Sci       Date:  2011-07-18       Impact factor: 4.849

10.  Disturbed relaxin signaling pathway and testicular dysfunction in mouse offspring upon maternal exposure to simazine.

Authors:  Ho-Oak Park; Jeehyeon Bae
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.